Ontology type: schema:ScholarlyArticle
1992-03
AUTHORSMatthias H. Seelig, Martin R. Berger, Bernhard K. Keppler
ABSTRACTThe antineoplastic activity of the ruthenium complexestrans-imidazolium[tetrachlorobisimidazoleruthenate(III)], HIm(RuIm2Cl4),trans-indazolium-[tetrachlorobis(1H-indazole)ruthenate(III,N2)], HInd [RuInd2Cl4(N2)], andtrans-indazolium[tetrachlorobis(2H-indazole)ruthenate(III,N1)], HInd[RuInd2Cl4-(N1)] was assessed in acetoxymethylmethylnitrosamine-induced autochthonous colorectal carcinomas of Sprague-Dawley rats. The model is not sensitive to clinically established antineoplastic agents, including cisplatin. An exception is the combination therapy with 5-fluorouracil/leucovorin, which shows moderate activity against the tumour model. In contrast to this general trend, the new substances were all active against this tumour. HIm(RuIm2Cl4) was very effective at all dosages applied (7.5 mg/kg, 5.3 mg/kg, and 3.8 mg/kg), as indicated by percentage treated/control (T/C values of 23%, 34.5%, and 44%. Toxicity was considerable as shown by a body weight change of −30%, −19%, and −9%. Nevertheless, the medium dose seems to be the optimum in terms of mortality (0% vs 15% in the control group), whereas at the highest dose, mortality increased as a result of substance toxicity, and at the lowest dose mortality increased through tumor growth combined with substance toxicity.HInd[RuInd2Cl4(N2)] showed high efficacy at the highest dosage of 13 mg/kg, reaching a T/C value of 27% combined with 0% mortality versus 15% in the control group. In equimolar dosages (10 mg/kg, 7.1 mg/kg and 5.1 mg/kg), the compound is not as active as HIm-(RuIm2Cl4), as indicated by T/C values of 50.2%, 45.7%, and 38.6%. HInd[RuInd2Cl4(N1)] was slightly but not significantly better than HInd[RuInd2Cl4(N2)] at a dosage of 7.1 mg/kg and is advantageous over combination therapy with 5-fluorouracil and leucovorin (20/20 mg/kg) in terms of efficacy (T/C=37.6% versus 44.7%) and mortality (6% versus 33.3%). More... »
PAGES195-200
http://scigraph.springernature.com/pub.10.1007/bf01410134
DOIhttp://dx.doi.org/10.1007/bf01410134
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1053560513
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/1548284
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Pharmacology and Pharmaceutical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Body Weight",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Colorectal Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dose-Response Relationship, Drug",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Imidazoles",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Indazoles",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Organometallic Compounds",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rats",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rats, Inbred Strains",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Ruthenium",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany",
"id": "http://www.grid.ac/institutes/grid.7497.d",
"name": [
"Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany"
],
"type": "Organization"
},
"familyName": "Seelig",
"givenName": "Matthias H.",
"id": "sg:person.01062355255.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062355255.01"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany",
"id": "http://www.grid.ac/institutes/grid.7497.d",
"name": [
"Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, W-6900, Heidelberg, Germany"
],
"type": "Organization"
},
"familyName": "Berger",
"givenName": "Martin R.",
"id": "sg:person.01256203524.22",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256203524.22"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Inorganic Chemistry, University of Heidelberg, Im Neuenheimer Feld 270, W-6900, Heidelberg, Germany",
"id": "http://www.grid.ac/institutes/grid.7700.0",
"name": [
"Institute of Inorganic Chemistry, University of Heidelberg, Im Neuenheimer Feld 270, W-6900, Heidelberg, Germany"
],
"type": "Organization"
},
"familyName": "Keppler",
"givenName": "Bernhard K.",
"id": "sg:person.0606573400.82",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606573400.82"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/bf00391842",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048398971",
"https://doi.org/10.1007/bf00391842"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-642-69600-8_28",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020422047",
"https://doi.org/10.1007/978-3-642-69600-8_28"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-642-74760-1_3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000987926",
"https://doi.org/10.1007/978-3-642-74760-1_3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00261487",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020513223",
"https://doi.org/10.1007/bf00261487"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01070878",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048388310",
"https://doi.org/10.1007/bf01070878"
],
"type": "CreativeWork"
}
],
"datePublished": "1992-03",
"datePublishedReg": "1992-03-01",
"description": "The antineoplastic activity of the ruthenium complexestrans-imidazolium[tetrachlorobisimidazoleruthenate(III)], HIm(RuIm2Cl4),trans-indazolium-[tetrachlorobis(1H-indazole)ruthenate(III,N2)], HInd [RuInd2Cl4(N2)], andtrans-indazolium[tetrachlorobis(2H-indazole)ruthenate(III,N1)], HInd[RuInd2Cl4-(N1)] was assessed in acetoxymethylmethylnitrosamine-induced autochthonous colorectal carcinomas of Sprague-Dawley rats. The model is not sensitive to clinically established antineoplastic agents, including cisplatin. An exception is the combination therapy with 5-fluorouracil/leucovorin, which shows moderate activity against the tumour model. In contrast to this general trend, the new substances were all active against this tumour. HIm(RuIm2Cl4) was very effective at all dosages applied (7.5 mg/kg, 5.3 mg/kg, and 3.8 mg/kg), as indicated by percentage treated/control (T/C values of 23%, 34.5%, and 44%. Toxicity was considerable as shown by a body weight change of \u221230%, \u221219%, and \u22129%. Nevertheless, the medium dose seems to be the optimum in terms of mortality (0% vs 15% in the control group), whereas at the highest dose, mortality increased as a result of substance toxicity, and at the lowest dose mortality increased through tumor growth combined with substance toxicity.HInd[RuInd2Cl4(N2)] showed high efficacy at the highest dosage of 13 mg/kg, reaching a T/C value of 27% combined with 0% mortality versus 15% in the control group. In equimolar dosages (10 mg/kg, 7.1 mg/kg and 5.1 mg/kg), the compound is not as active as HIm-(RuIm2Cl4), as indicated by T/C values of 50.2%, 45.7%, and 38.6%. HInd[RuInd2Cl4(N1)] was slightly but not significantly better than HInd[RuInd2Cl4(N2)] at a dosage of 7.1 mg/kg and is advantageous over combination therapy with 5-fluorouracil and leucovorin (20/20 mg/kg) in terms of efficacy (T/C=37.6% versus 44.7%) and mortality (6% versus 33.3%).",
"genre": "article",
"id": "sg:pub.10.1007/bf01410134",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1313647",
"issn": [
"0171-5216",
"1432-1335"
],
"name": "Journal of Cancer Research and Clinical Oncology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "118"
}
],
"keywords": [
"Sprague-Dawley rats",
"combination therapy",
"colorectal carcinoma",
"tumor model",
"antineoplastic agents",
"antineoplastic activity",
"moderate activity",
"leucovorin",
"new substances",
"carcinoma",
"therapy",
"tumors",
"rats",
"cisplatin",
"hind",
"activity",
"dosage",
"agents",
"percentage",
"control",
"substances",
"contrast",
"exception",
"trends",
"model",
"general trend",
"indazolium",
"andtrans"
],
"name": "Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats",
"pagination": "195-200",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1053560513"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/bf01410134"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"1548284"
]
}
],
"sameAs": [
"https://doi.org/10.1007/bf01410134",
"https://app.dimensions.ai/details/publication/pub.1053560513"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T21:59",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_244.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/bf01410134"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01410134'
This table displays all metadata directly associated to this object as RDF triples.
179 TRIPLES
22 PREDICATES
73 URIs
60 LITERALS
20 BLANK NODES